tirzepatide weight loss san diego Programs In CA Tirzepatide use in People with

For example, the SURMOUNT-5 trial showed that tirzepatide (Zepbound) helped patients achieve roughly 20% weight loss, compared to 14% with semaglutide (Wegovy)

As in adults, gastrointestinal adverse effects were commonly seen

Obesity, sleep apnea, chronic stress, and sedentary behavior all dampen the HPG axis

Timeline: Sleep improvements may begin relatively quickly (within weeks to months) as weight decreases, though full effect correlates with maximum weight loss

Such studies are inherently susceptible to confounding by socioeconomic status, access to healthcare, reimbursement policies, and patient adherence, all of which may significantly impact treatment continuation and metabolic outcomes